IFIMOL (Paracetamol)

OVERVIEW

IFIMOL is the market leader in Paracetamol I.V. in the Philippines and is in the top 200 hospital ethical products based on Dec 2018 IQVIA Report. PREMIXED, READY-TO-USE containing a therapeutic dose of 1 g paracetamol for adults. Can be administered as a rapid infusion with no significant infusion-related side effects.

IFIMOL was launched by Delex Pharma in May 2013 and is available in almost all major tertiary hospitals and selected Mercury Drug branches.

PRODUCT DESCRIPTION

Generic Name: PARACETAMOL
Brand Name: Ifimol
Preparation: 10 mg/mL in 100 mL vial
Name of Manufacturer: Unique Pharmaceutical Laboratories
Place of Manufacturer: India
Shelf Life: 24 months
Storage condition: Store at temperature not exceeding 300C
Packaging: USP Type I Flint glass vial (Box of 1’s)
FDA Registration No: DRP-392

ABOUT THE MANUFACTURER

Unique Pharmaceutical Laboratories is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented and public listed organization with focus on supplying affordable and quality products both in India and International markets. Unique is trusted by healthcare professionals globally. Today, the company exports to over thirty (30) countries across the world and earns more than half its revenue from its international business.

Unique has its headquarters in India’s financial capital, Mumbai. With a domestic sales force of 1,000 people, 17 internationally approved state-of-the-art manufacturing units, a Research and Development (R&D) Centre, and subsidiaries abroad, the organization is continually enhancing value for its shareholders.

INTRAFEN (Ibuprofen)

OVERVIEW

INTRAFEN is the first and only Ibuprofen brand in I.V. preparation launched in the Philippines. Ibuprofen has been rated as the safest conventional NSAID by spontaneous adverse drug reaction reporting system in the UK.1

INTRAFEN was launched by Delex Pharma in Aug 2018 and is available in selected Mercury Drug branches.

1. Rabia Bushra, et. al., An Overview of Clinical Pharmacology of Ibuprofen, Oman Medical Journal 2010, Volume 25, Issue 3, July 2010
PRODUCT DESCRIPTION

Generic Name: IBUPROFEN
Brand Name: Intrafen
Preparation: 100 mg/mL in 4 mL & 8 mL vials
Name of Manufacturer: Mefar Ilac Sanayii A.S.
Place of Manufacturer: Turkey
Shelf Life: 24 months
Storage condition: Store at temperature not exceeding 300C
Packaging: 4 mL in 6 mL-capacity USP Type I clear and colorless glass vial; 8 mL in 10 mL-capacity USP Type I clear and colorless glass vial
FDA Registration No: DR-XY46120 (4 mL); DR-XY46190 (8 mL)

ABOUT THE MANUFACTURER

Mefar is a leading pharmaceutical contract manufacturer of parenteral solutions for human and veterinary usage in ampoules, vials, BFS (blow-fill-seal), PFS (pre-filled syringes) and freeze dried products in Turkey. It is also the first company to fill vaccines in Turkey in its new state-of-the-art facility. For sterile (aseptically or terminally sterilized & filled) drug manufacturing, Mefar is certified to cGMP/cGLPby European Authorities and heavily exports to many Western and Eastern EU countries.

Mefar is now the first company in pharmaceutical industry that is certificated with ISO 45001 Occupational Health and Safety Management System.

KETOROLEX (Ketorolac Trometamol)

OVERVIEW

KETOROLEX is manufactured by a South Korean company with presence in Austria, Denmark, Estonia, Iceland, and Luxembourg.

PRODUCT DESCRIPTION

Generic Name: KETOROLAC Trometamol
Brand Name: Ketorolex
Preparation: 30 mg/mL in ampoule
Name of Manufacturer: Myungmoon Pharmaceutical Co. Ltd.
Place of Manufacturer: South Korea
Shelf Life: 36 months
Storage condition: Store at temperature not exceeding 300C. Protect from light
Packaging: Amber glass ampoule (Box of 10’s)
FDA Registration No: DRP-2382-06

ABOUT THE MANUFACTURER

Since its founding in South Korea in 1983, Myungmoon Pharm. Co., LTD. has become a multi-million company with net worth of $540 million in 2015. The company produces more than 250 specialized and general medicines and more than 400 specialized and general medicine licenses. Myungmoon launches more than 20 new products every year. Its 500 employees are focused in providing excellent service to the company’s growing clientele in the Asian market.

LEXOFOL (Propofol)

OVERVIEW

LEXOFOL is one of the few Propofol brands in the Philippines available in vial preparation. Its manufacturer has a respectable reputation in anesthetic and critical care segments, with presence in Europe, South America, Africa and Asia.

PRODUCT DESCRIPTION

Generic Name: PROPOFOL
Brand Name: Lexofol
Preparation: 10 mg/mL (1% w/v Emulsion for Injection)
Name of Manufacturer: Neon Laboratories Limited
Place of Manufacturer: India
Shelf Life: 18 months
Storage condition: Store at temperature not exceeding 250C
Packaging: USP Type I Flint Glass vial (Box of 1’s)
FDA Registration No: DRP-3206

ABOUT THE MANUFACTURER

Established in 1982, Neon Laboratories has earned reputation as one of the leading pharmaceutical companies in India. They have established global presence by supplying high quality branded generic formulations in ASIA, Africa, Latin America and CIS. As of to date, the company has registered more than 300 products in 60 different countries.

TRAMADEX (Tramadol hydrochloride)

OVERVIEW

TRAMADEX is manufactured by a reputable company in South Korea with Certificate of Current Good Manufacturing Practice (cCMP), and has presence in Ireland, USA, France, China, Japan and India.

PRODUCT DESCRIPTION

Generic Name: TRAMADOL hydrochloride
Brand Name: Tramadex
Preparation: 50 mg/mL (100 mg/2 mL) in ampoule
Name of Manufacturer: Ahngook Pharmaceutical Co. Ltd.
Place of Manufacturer: South Korea
Shelf Life: 36 months
Storage condition: Store at temperature not exceeding 250C
Packaging: Type I Amber glass ampoule (Box of 10’s)
FDA Registration No: DR-XY27009

ABOUT THE MANUFACTURER

Ahngook Pharmaceutical Co., Ltd. has developed and supplied outstanding medicines for the last 45 years and achieved KOSDAQ (a trading board of Korea Exchange in South Korea established in 1996) enlistment.

To date, the company is accumulating core technology to develop new world-class medicines, and fostering key manpower that can develop and market new medicines.

The company was enlisted in “Top 100 Transparent Companies” by Seoul Economy Newspaper in 2001 and won the “Best Human Resources Management in Korea” award in 2002.